Related Experiment Videos
Decision-making control: why men decline treatment for prostate cancer
Margaret A White1, Marja J Verhoef
1Vancouver, British Columbia.
Integrative Cancer Therapies
|March 24, 2004
Summary
Men with prostate cancer often control their treatment decisions when choosing alternative therapies. They focus on timing, information, planning, care coordination, and monitoring disease progression.
Area of Science:
- Oncology
- Qualitative Research
Background:
- Men with prostate cancer frequently decline conventional treatments.
- Exploring patient decision-making control is crucial for understanding treatment choices.
Purpose of the Study:
- To qualitatively analyze decision-making control in men with prostate cancer who refuse conventional therapies.
- To explore factors influencing control over treatment decisions.
Main Methods:
- Qualitative analysis of transcripts from 8 prostate cancer patients.
- In-depth exploration of decision-making control factors.
Main Results:
- Most men were newly diagnosed when opting for alternative treatments.
- Patients exerted control over treatment timing, information access, alternative plan design, care coordination, and disease monitoring.
- Clinicians can support these patients by respecting their control, integrating complementary therapies, addressing fears, and fostering open communication.
Conclusions:
- Men with prostate cancer actively manage their treatment process when choosing alternatives.
- Supporting patient autonomy and open communication is key for clinicians.
- Further quantitative research is needed to validate these findings.